GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Apex Healthcare Bhd (XKLS:7090) » Definitions » Risk Assessment

Apex Healthcare Bhd (XKLS:7090) Risk Assessment


View and export this data going back to 2000. Start your Free Trial

What is Apex Healthcare Bhd Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Apex Healthcare Bhd is: Low Risk: Strong fundamentals, worth long-term holding.


Competitive Comparison of Apex Healthcare Bhd's Risk Assessment

For the Medical Distribution subindustry, Apex Healthcare Bhd's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apex Healthcare Bhd's Risk Assessment Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Apex Healthcare Bhd's Risk Assessment falls into.



Apex Healthcare Bhd  (XKLS:7090) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Apex Healthcare Bhd Risk Assessment Related Terms

Thank you for viewing the detailed overview of Apex Healthcare Bhd's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Apex Healthcare Bhd (XKLS:7090) Business Description

Traded in Other Exchanges
N/A
Address
1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing and marketing of pharmaceutical products; Wholesale and distribution of pharmaceutical and healthcare products; and Corporate comprising investments, properties, and others.

Apex Healthcare Bhd (XKLS:7090) Headlines

No Headlines